Czechia – Antineoplastic agents – Dodávky léků – Léčivá látka nintedanib – ATC L01EX09
Opportunity Score
Confidence: 60%
Complexity: low
9 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender by Fakultní Thomayerova nemocnice (Prague, Czech Republic) seeks the supply of the antineoplastic agent nintedanib (ATC L01EX09) in four specified pack sizes and quantities, with a total estimated value of 187,979,990 CZK. The procedure is an open tender with a single lot, award based on lowest price, and requires electronic submission in Czech by 24 June 2026. Key procurement documents are available but were not analyzed, and eligibility criteria are not explicitly provided in the notice.
Strengths
Documents available
Open procedure
Low complexity
Risks
Submission deadline in 9 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Supply of nintedanib in four specified presentations: 100MG CPS MOL 30x100MG (9,500 units), 100MG CPS MOL 60x100MG (3,000 units), 150MG CPS MOL 30x150MG (8,500 units), 150MG CPS MOL 60x150MG (4,500 units)
- Award based solely on lowest price
- Electronic submission required via the buyer's profile
Award Criteria
nejnižší nabídková cena
Hodnocení nabídek bude provedeno podle § 114 odst. 2. ZZVZ tak, že zadavatel bude hodnotit podle nejnižší nabídkové ceny. Nabídka s nejnižší nabídkovou cenou bude hodnocena jako nejvýhodnější (§ 115 ZZVZ).
| Criterion | Type |
|---|---|
nejnižší nabídková cena Hodnocení nabídek bude provedeno podle § 114 odst. 2. ZZVZ tak, že zadavatel bude hodnotit podle nejnižší nabídkové ceny. Nabídka s nejnižší nabídkovou cenou bude hodnocena jako nejvýhodnější (§ 115 ZZVZ). | Price |
Buyer
Name
Fakultní Thomayerova nemocnice
Location
Praha, CZE
Buyer profile
Identifier
00064190
Lots (1)
Supply of nintedanib in four forms: 100MG CPS MOL 30x100MG (9,500 units), 100MG CPS MOL 60x100MG (3,000 units), 150MG CPS MOL 30x150MG (8,500 units), and 150MG CPS MOL 60x150MG (4,500 units).
Procurement Details
Publication
01 Jun 2026
Deadline
24 Jun 2026, 07:00
Procedure
open
Contract
supplies
Language
CES
Publication #
374929-2026
Classification
Performance: Czech Republic
Documents (2)
Opportunity Score
Confidence: 60%
Complexity: low
9 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation